Usability and relevance of specialized population-based cancer registry data in externally controlled trials.
BACKGROUND Randomized clinical trials are becoming very challenging to perform in oncology both in rare cancers and in more common cancers, fragmented according to molecular characteristics. OBJECTIVE In this proof of concept, we tested the feasibility of using data from a specialized digestive cancer registry as an...